Cargando…
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with those of olmesartan in Japanese patients with essential hypertension. Patients (n = 1161, aged ≥20 years) with mild to moderate hypertension (mean sitting systolic blood pressure [msSBP] ≥150 to <180 mmHg)...
Autores principales: | Rakugi, Hiromi, Kario, Kazuomi, Yamaguchi, Masako, Sasajima, Takayoshi, Gotou, Hiromi, Zhang, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010294/ https://www.ncbi.nlm.nih.gov/pubmed/35058583 http://dx.doi.org/10.1038/s41440-021-00819-7 |
Ejemplares similares
-
Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study
por: Kario, Kazuomi, et al.
Publicado: (2023) -
Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension
por: Zhang, Yaling, et al.
Publicado: (2022) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)